Posted On: 10/10/2012 8:35:10 PM
Post# of 165
$IMUN Research report!
| IMMUNOVATIVE, INC. The Only Way to Treat Cancer | |
| Rob Goldman August 3, 2012 | |
| IMMUNOVATIVE, INC. (OTC:BB - IMUN - $0.22) | |
| Price Target: $1.70 | Rating: Speculative Buy |
http://www.goldmanresearch.com/Popular/the-on...ancer.html
(0)
(0)
